Efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell carcinoma: a prospective cohort study with propensity-score matching
For locally advanced ESCC, neoadjuvant immunochemotherapy significantly improves both PFS and OS compared to upfront surgery, establishing it as a highly effective treatment strategy.
Authors
- Shifa Zhang (ORCID: https://orcid.org/0000-0002-7361-9336)
- gongchao wang
- Haibo Cai
- Wei Yutao
- Jishan ZHANG
- Anhao Hu
- Jiuhe Sun
Institutions
- Shandong Provincial Hospital (CN)
- Jining First People's Hospital (CN)
- Affiliated Hospital of Jining Medical University (CN)
- Jining Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.3389/fimmu.2025.1711095
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 39.15